Pfizer: Think Patient-First when Developing Mobile Health Apps

NYC-based pharma company Pfizer currently has 15 apps in the US iOS app store, ranging from a chapstick companion app to an app for people with kidney cancer. At the HIMSS Connected Health Summit in National Harbor, Maryland, Pfizer executives talked about two of the company’s apps and their broader strategy for developing mobile health interventions. Continue reading

Pfizer Latest Drug Company Caught Off-Label Marketing

The next time you’re stuck at a convenience store behind some guy buying dozens of Powerball tickets, take pity on the poor fellow — he just may be a former Pfizer executive.

A federal appeals court recently upheld a staggering $142 million judgment against the drug giant Continue reading

Inside The Pricing of a $300,000-A-Year Drug

David Grainger Raises very nicely (but does not answer!) the question of orphan drug pricing. James Your comments caused me to do some math, and trying to figure out just where and how long the “break even” point lies with the drug.

Last night, NPS Pharmaceuticals announced that it was pricing Gattex, its drug for short bowel syndrome, at $295,000 per patient per year, Continue reading

Top 10 Drug Company Settlements

Story at-a-glance

  • A record 4.02 billion prescriptions were written in the United States in 2011, showing Americans are taking more drugs than ever before and putting their health in the hands of some of the top corporate criminals in the world
  • Drug company settlements continue to be commonplace Continue reading

The Last Antibiotic: Drug Companies Run out of Weapons Against the Very Same Superbugs they Helped Create

The age of antibiotics is over. It’s history. There are no more patented chemical antibiotics in the pipeline. The drug companies have all but abandoned antibiotics research, leaving humanity to suffer the fate of a wave of drug-resistant bacteria — superbugs — that the drug companies actually helped create.

The industry is down Continue reading